Shopping Cart
Remove All
Your shopping cart is currently empty
[Orn8]-Urotensin II acetate is a Urotensin receptor ligand and a partial agonist at Urotensin receptors.
![[Orn8]-Urotensin II acetate](https://cdn.targetmol.com/group3/M00/03/78/CgoaEWY7TQ6EUeDdAAAAACBmgjU168.png)
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | - | In Stock | |
| 5 mg | $437 | - | In Stock | |
| 10 mg | $646 | - | In Stock | |
| 25 mg | $987 | - | In Stock | |
| 50 mg | $1,380 | - | In Stock | |
| 100 mg | $1,860 | - | In Stock |
| Description | [Orn8]-Urotensin II acetate is a Urotensin receptor ligand and a partial agonist at Urotensin receptors. |
| Targets&IC50 | UT receptor/GPR14:8 (pEC50) |
| In vivo | [Orn8]-Urotensin II acetate behaves as a full agonist (pEC50 approximately equal 8) at both human and rat UT receptors in the FlipR calcium assay eliciting similar maximal effects as the natural ligand U-II. On the contrary, in the rat aorta bioassay, [Orn8]-Urotensin II acetate behaves as a competitive and selective antagonist (pA2 = 6.56) showing however a small but consistent residual agonist activity[2]. |
| Molecular Weight | 1434.59 |
| Formula | C65H87N13O20S2 |
| Smiles | O=C([C@H]([C@@H](C)O)NC([C@@H](N)CCC(O)=O)=O)N(CCC1)[C@H]1C(N[C@H](CC(O)=O)C(N[C@H]2C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CC4=CNC5=C4C=CC=C5)C(N[C@@H](C(N[C@@H](CC6=CC=C(O)C=C6)C(N[C@H](C(N[C@H](C(C)C)C(O)=O)=O)CSSC2)=O)=O)CCCN)=O)=O)=O)=O)=O.CC(O)=O |
| Sequence | Glu-Thr-Pro-Asp-Cys(1)-Phe-Trp-Orn-Tyr-Cys(1)-Val |
| Sequence Short | ETPDCFWXYCV |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 14.35 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.